{
  "Pre-Authorization Form Fields": [
    {
      "subheading": "General Request Details",
      "fields": [
        {
          "name": "Request Type",
          "type": "single_select",
          "options": [
            {
              "value": "Start of treatment",
              "fields": [
                {
                  "name": "Start Date",
                  "type": "date"
                }
              ]
            },
            {
              "value": "Continuation of therapy",
              "fields": [
                {
                  "name": "Date of Last Treatment",
                  "type": "date"
                }
              ]
            }
          ]
        },
        {
          "name": "Precertification Requested By",
          "type": "string"
        },
        {
          "name": "Precertification Requested By Phone",
          "type": "string"
        },
        {
          "name": "Precertification Requested By Fax",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "A. PATIENT INFORMATION",
      "fields": [
        {
          "name": "First Name",
          "type": "string"
        },
        {
          "name": "Last Name",
          "type": "string"
        },
        {
          "name": "Date of Birth",
          "type": "date"
        },
        {
          "name": "Address",
          "type": "string"
        },
        {
          "name": "City",
          "type": "string"
        },
        {
          "name": "State",
          "type": "string"
        },
        {
          "name": "ZIP",
          "type": "string"
        },
        {
          "name": "Home Phone",
          "type": "string"
        },
        {
          "name": "Work Phone",
          "type": "string"
        },
        {
          "name": "Cell Phone",
          "type": "string"
        },
        {
          "name": "E-mail",
          "type": "string"
        },
        {
          "name": "Current Weight",
          "type": "number",
          "units": [
            "lbs",
            "kgs"
          ]
        },
        {
          "name": "Height",
          "type": "number",
          "units": [
            "inches",
            "cms"
          ]
        },
        {
          "name": "Allergies",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "B. INSURANCE INFORMATION",
      "fields": [
        {
          "name": "Member ID #",
          "type": "string"
        },
        {
          "name": "Does patient have other coverage?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Does patient have other coverage?",
                "value": "Yes"
              },
              "fields": [
                {
                  "name": "Other Coverage ID #",
                  "type": "string"
                },
                {
                  "name": "Other Coverage Carrier Name",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Group #",
          "type": "string"
        },
        {
          "name": "Insured_1",
          "type": "string"
        },
        {
          "name": "Insured_2",
          "type": "string"
        },
        {
          "name": "Insured_3",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "C. PRESCRIBER INFORMATION",
      "fields": [
        {
          "name": "First Name",
          "type": "string"
        },
        {
          "name": "Last Name",
          "type": "string"
        },
        {
          "name": "Prescriber Type",
          "type": "single_select",
          "options": [
            "M.D.",
            "D.O.",
            "N.P.",
            "P.A."
          ]
        },
        {
          "name": "Address",
          "type": "string"
        },
        {
          "name": "City",
          "type": "string"
        },
        {
          "name": "State",
          "type": "string"
        },
        {
          "name": "ZIP",
          "type": "string"
        },
        {
          "name": "Phone",
          "type": "string"
        },
        {
          "name": "Fax",
          "type": "string"
        },
        {
          "name": "State License #",
          "type": "string"
        },
        {
          "name": "NPI #",
          "type": "string"
        },
        {
          "name": "DEA #",
          "type": "string"
        },
        {
          "name": "UPIN",
          "type": "string"
        },
        {
          "name": "Provider Email",
          "type": "string"
        },
        {
          "name": "Office Contact Name",
          "type": "string"
        },
        {
          "name": "Office Contact Phone",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "D. DISPENSING PROVIDER/ADMINISTRATION INFORMATION",
      "fields": [
        {
          "name": "Place of Administration",
          "type": "multi_select",
          "options": [
            "Self-administered",
            "Physician's Office",
            "Home",
            "Outpatient Dialysis Center",
            "Outpatient Infusion Center",
            "Home Infusion Center",
            "Other"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Place of Administration",
                "value": "Other"
              },
              "fields": [
                {
                  "name": "Other Place of Administration (Specify)",
                  "type": "string"
                }
              ]
            },
            {
              "condition": {
                "field": "Place of Administration",
                "value": "Home Infusion Center"
              },
              "fields": [
                {
                  "name": "Home Infusion Agency Name",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Dispensing Provider/Pharmacy Type",
          "type": "multi_select",
          "options": [
            "Physician's Office",
            "Retail Pharmacy",
            "Specialty Pharmacy",
            "Mail Order",
            "Other"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Dispensing Provider/Pharmacy Type",
                "value": "Other"
              },
              "fields": [
                {
                  "name": "Other Dispensing Provider/Pharmacy Name (Specify)",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Dispensing Provider/Pharmacy Name",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy Address",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy City",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy State",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy ZIP",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy Phone",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy Fax",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy TIN",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy PIN",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy NPI 1",
          "type": "string"
        },
        {
          "name": "Dispensing Provider/Pharmacy NPI 2",
          "type": "string"
        },
        {
          "name": "Administration Code(s) (CPT)",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "E. PRODUCT INFORMATION",
      "fields": [
        {
          "name": "Request is for",
          "type": "single_select",
          "options": [
            "Riabni (rituximab-arrx)",
            "Rituxan (rituximab)",
            "Ruxience (rituximab-pvvr)",
            "Truxima (rituximab-abbs)"
          ]
        },
        {
          "name": "Dose",
          "type": "string"
        },
        {
          "name": "Directions for Use",
          "type": "string"
        },
        {
          "name": "HCPCS Code",
          "type": "string"
        }
      ]
    },
    {
      "subheading": "F. DIAGNOSIS INFORMATION",
      "fields": [
        {
          "name": "Primary ICD Code",
          "type": "string"
        },
        {
          "name": "Other ICD Code",
          "type": "string",
          "optional": true
        }
      ]
    },
    {
      "subheading": "G. CLINICAL INFORMATION",
      "fields": [
        {
          "name": "Has the patient had prior therapy with the requested product within the last 365 days?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ]
        },
        {
          "name": "Has the patient had a trial and failure of any of the following rituximab biosimilars?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Has the patient had a trial and failure of any of the following rituximab biosimilars?",
                "value": "Yes"
              },
              "fields": [
                {
                  "name": "Failed Rituximab Biosimilars",
                  "type": "multi_select",
                  "options": [
                    "Ruxience (rituximab-pvvr)",
                    "Truxima (rituximab-abbs)"
                  ]
                },
                {
                  "name": "When was the member's trial and failure of the preferred drug?",
                  "type": "string"
                },
                {
                  "name": "Please describe the nature of the failure of the preferred drug",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Has the patient had an adverse reaction to any of the following rituximab biosimilars?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Has the patient had an adverse reaction to any of the following rituximab biosimilars?",
                "value": "Yes"
              },
              "fields": [
                {
                  "name": "Adverse Reaction Rituximab Biosimilars",
                  "type": "multi_select",
                  "options": [
                    "Ruxience (rituximab-pvvr)",
                    "Truxima (rituximab-abbs)"
                  ]
                },
                {
                  "name": "When was the member's adverse reaction to the preferred drug?",
                  "type": "string"
                },
                {
                  "name": "Please describe the nature of the adverse reaction to the preferred drug",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Contraindications or other medical reasons patient cannot use preferred biosimilar products (select all that apply)",
          "type": "multi_select",
          "options": [
            "Ruxience (rituximab-pvvr)",
            "Truxima (rituximab-abbs)"
          ]
        },
        {
          "name": "Has the patient had a trial and failure of any of the following (MA plans)?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Has the patient had a trial and failure of any of the following (MA plans)?",
                "value": "Yes"
              },
              "fields": [
                {
                  "name": "Failed MA Plan Drugs",
                  "type": "multi_select",
                  "options": [
                    "Inflectra (infliximab-dyyb)",
                    "Renflexis (infliximab-abda)",
                    "Simponi Aria (golimumab)"
                  ]
                },
                {
                  "name": "When was the member's trial and failure of the preferred drug (MA plans)?",
                  "type": "string"
                },
                {
                  "name": "Please describe the nature of the failure of the preferred drug (MA plans)",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Has the patient had an adverse reaction to any of the following (MA plans)?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Has the patient had an adverse reaction to any of the following (MA plans)?",
                "value": "Yes"
              },
              "fields": [
                {
                  "name": "Adverse Reaction MA Plan Drugs",
                  "type": "multi_select",
                  "options": [
                    "Inflectra (infliximab-dyyb)",
                    "Renflexis (infliximab-abda)",
                    "Simponi Aria (golimumab)"
                  ]
                },
                {
                  "name": "When was the member's adverse reaction to the preferred drug (MA plans)?",
                  "type": "string"
                },
                {
                  "name": "Please describe the nature of the adverse reaction to the preferred drug (MA plans)",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Has the patient had a trial and failure of any of the following (MAPD plans - Set 1)?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Has the patient had a trial and failure of any of the following (MAPD plans - Set 1)?",
                "value": "Yes"
              },
              "fields": [
                {
                  "name": "Failed MAPD Plan Drugs Set 1",
                  "type": "multi_select",
                  "options": [
                    "Enbrel (etanercept)",
                    "Humira (adalimumab)",
                    "Idacio (adalimumab-aacf)",
                    "Rinvoq (upadacitinib)",
                    "Tyenne SC (tocilizumab-aazg)",
                    "Xeljanz/Xeljanz XR (tofacitinib)"
                  ]
                },
                {
                  "name": "When was the member's trial and failure of the preferred drug (MAPD plans - Set 1)?",
                  "type": "string"
                },
                {
                  "name": "Please describe the nature of the failure of the preferred drug (MAPD plans - Set 1)",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Has the patient had a trial and failure of any of the following (MAPD plans - Set 2)?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ],
          "contingent_fields": [
            {
              "condition": {
                "field": "Has the patient had a trial and failure of any of the following (MAPD plans - Set 2)?",
                "value": "Yes"
              },
              "fields": [
                {
                  "name": "Failed MAPD Plan Drugs Set 2",
                  "type": "multi_select",
                  "options": [
                    "Enbrel (etanercept)",
                    "Humira (adalimumab)",
                    "Idacio (adalimumab-aacf)",
                    "Rinvoq (upadacitinib)",
                    "Tyenne SC (tocilizumab-aazg)",
                    "Xeljanz/Xeljanz XR (tofacitinib)"
                  ]
                },
                {
                  "name": "When was the member's adverse reaction to the preferred drug (MAPD plans - Set 2)?",
                  "type": "string"
                },
                {
                  "name": "Please describe the nature of the adverse reaction to the preferred drug (MAPD plans - Set 2)",
                  "type": "string"
                }
              ]
            }
          ]
        },
        {
          "name": "Contraindications or other medical reasons patient cannot use preferred products (MA plans) (select all that apply)",
          "type": "multi_select",
          "options": [
            "Inflectra (infliximab-dyyb)",
            "Renflexis (infliximab-abda)",
            "Simponi Aria (golimumab)"
          ]
        },
        {
          "name": "Contraindications or other medical reasons patient cannot use preferred products (MAPD plans) (select all that apply)",
          "type": "multi_select",
          "options": [
            "Enbrel (etanercept)",
            "Humira (adalimumab)",
            "Idacio (adalimumab-aacf)",
            "Rinvoq (upadacitinib)",
            "Tyenne SC (tocilizumab-aazg)",
            "Xeljanz/Xeljanz XR (tofacitinib)"
          ]
        },
        {
          "name": "Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
          "type": "boolean",
          "options": [
            "Yes",
            "No"
          ]
        },
        {
          "subheading": "Acute lymphoid leukemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            },
            {
              "name": "Is Rituxan (rituximab) being used as induction/consolidation therapy?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "Autoimmune hemolytic anemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides",
          "fields": [
            {
              "name": "Which of the following applies to the patient?",
              "type": "single_select",
              "options": [
                "Wegener granulomatosis",
                "Churg-Strauss syndrome",
                "Microscopic polyangiitis",
                "pauci-immune glomerulonephritis"
              ]
            },
            {
              "name": "Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "Autoimmune blistering diseases, corticosteroid-refractory",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ],
              "contingent_fields": [
                {
                  "condition": {
                    "field": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
                    "value": "Yes"
                  },
                  "fields": [
                    {
                      "name": "Which blistering disease applies to the patient?",
                      "type": "single_select",
                      "options": [
                        "pemphigus vulgaris",
                        "pemphigus folliaceus",
                        "bullous pemphigoid",
                        "cicatricial pemphigoid",
                        "epidermolysis bullosa acquisita",
                        "paraneoplastic pemphigus",
                        "None of the above"
                      ]
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "B-cell lymphomas",
          "fields": [
            {
              "name": "Which B-cell lymphoma applies to the patient?",
              "type": "multi_select",
              "options": [
                "AIDS-related B-cell lymphoma",
                "Burkitt lymphoma",
                "Diffuse large B-cell lymphoma",
                "Follicular lymphoma",
                "Gastric MALT lymphoma",
                "High-grade B-Cell lymphoma",
                "Mantle cell lymphoma",
                "Nodal marginal zone lymphoma",
                "Nongastric MALT lymphoma",
                "Primary cutaneous B-cell lymphomas",
                "Splenic marginal zone lymphoma",
                "Other"
              ],
              "contingent_fields": [
                {
                  "condition": {
                    "field": "Which B-cell lymphoma applies to the patient?",
                    "value": "Other"
                  },
                  "fields": [
                    {
                      "name": "Other B-cell lymphoma (Specify)",
                      "type": "string"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "Castleman's disease",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of multicentric Castleman's disease (angiofollicular lymph node hyperplasia)?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "Central nervous system lymphomas",
          "fields": [
            {
              "name": "Which CNS lymphoma applies to the patient?",
              "type": "single_select",
              "options": [
                "leptomeningeal metastases from lymphoma",
                "primary CNS lymphoma",
                "none of the above"
              ]
            }
          ]
        },
        {
          "subheading": "Chronic or small lymphocytic leukemia",
          "fields": [
            {
              "name": "Which chronic or small lymphocytic leukemia applies to the patient?",
              "type": "single_select",
              "options": [
                "chronic lymphocytic leukemia (CLL)",
                "small lymphocytic leukemia",
                "none of the above"
              ]
            }
          ]
        },
        {
          "subheading": "Cryoglobulinemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of cryoglobulinemia?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            },
            {
              "name": "Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "Graft versus host disease, chronic",
          "fields": [
            {
              "name": "Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "Hairy cell leukemia",
          "fields": [
            {
              "name": "Which hairy cell leukemia applies to the patient?",
              "type": "single_select",
              "options": [
                "relapsed hairy cell leukemia",
                "refractory hairy cell leukemia",
                "none of the above"
              ]
            }
          ]
        },
        {
          "subheading": "Heart and solid organ transplant",
          "fields": [
            {
              "name": "Is Rituxan (rituximab) being used for treatment or prevention (desensitization) of highly sensitized patients with antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ],
              "contingent_fields": [
                {
                  "condition": {
                    "field": "Is Rituxan (rituximab) being used for treatment or prevention (desensitization) of highly sensitized patients with antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients?",
                    "value": "Yes"
                  },
                  "fields": [
                    {
                      "name": "Which transplant recipient type applies to the patient?",
                      "type": "single_select",
                      "options": [
                        "heart transplant recipient",
                        "other solid organ transplant recipient"
                      ]
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "Immune checkpoint-inhibitor related encephalitis",
          "fields": [
            {
              "name": "Which immune check-point inhibitor caused the encephalitis?",
              "type": "multi_select",
              "options": [
                "Bavencio (avelumab)",
                "Imfinzi (durvalumab)",
                "Keytruda (pembrolizumab)",
                "Opdivo (nivolumab)",
                "Tecentriq (atezolizumab)",
                "Yervoy (ipilimumab)",
                "Other"
              ],
              "contingent_fields": [
                {
                  "condition": {
                    "field": "Which immune check-point inhibitor caused the encephalitis?",
                    "value": "Other"
                  },
                  "fields": [
                    {
                      "name": "Other Immune Check-point Inhibitor (Specify)",
                      "type": "string"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "Rheumatoid Arthritis",
          "fields": [
            {
              "name": "Severity of the patient's rheumatoid arthritis",
              "type": "single_select",
              "options": [
                "Mild",
                "Moderate",
                "Severe"
              ]
            },
            {
              "name": "Is there evidence that the disease is active?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            },
            {
              "name": "Will Rituxan (rituximab) be used in combination with methotrexate?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ],
              "contingent_fields": [
                {
                  "condition": {
                    "field": "Will Rituxan (rituximab) be used in combination with methotrexate?",
                    "value": "Yes"
                  },
                  "fields": [
                    {
                      "name": "Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
                      "type": "boolean",
                      "options": [
                        "Yes",
                        "No"
                      ],
                      "contingent_fields": [
                        {
                          "condition": {
                            "field": "Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
                            "value": "Yes"
                          },
                          "fields": [
                            {
                              "name": "Reason for methotrexate treatment issue",
                              "type": "single_select",
                              "options": [
                                "ineffective",
                                "not tolerated",
                                "contraindicated"
                              ]
                            }
                          ]
                        }
                      ]
                    }
                  ]
                }
              ]
            },
            {
              "name": "Was treatment with another conventional DMARD ineffective?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ],
              "contingent_fields": [
                {
                  "condition": {
                    "field": "Was treatment with another conventional DMARD ineffective?",
                    "value": "Yes"
                  },
                  "fields": [
                    {
                      "name": "Ineffective conventional DMARDs",
                      "type": "multi_select",
                      "options": [
                        "azathioprine",
                        "cyclosporine",
                        "hydroxychloroquine",
                        "leflunomide",
                        "sulfasalazine"
                      ]
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "Sj\u00f6gren syndrome",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of Sj\u00f6gren's syndrome?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            },
            {
              "name": "Was treatment with corticosteroids and other immunosuppressive agents ineffective?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ],
              "contingent_fields": [
                {
                  "condition": {
                    "field": "Was treatment with corticosteroids and other immunosuppressive agents ineffective?",
                    "value": "Yes"
                  },
                  "fields": [
                    {
                      "name": "Medication 1 (Corticosteroids/Immunosuppressants)",
                      "type": "string"
                    },
                    {
                      "name": "Dates 1 (Corticosteroids/Immunosuppressants)",
                      "type": "date"
                    },
                    {
                      "name": "Medication 2 (Corticosteroids/Immunosuppressants)",
                      "type": "string"
                    },
                    {
                      "name": "Dates 2 (Corticosteroids/Immunosuppressants)",
                      "type": "date"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "subheading": "Thrombotic thrombocytopenic purpura",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "Waldenstrom's macroglobulinemia",
          "fields": [
            {
              "name": "Does the patient have a documented diagnosis of Waldenstr\u00f6m macroglobulinemia?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            }
          ]
        },
        {
          "subheading": "For Continuation Requests",
          "fields": [
            {
              "name": "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?",
              "type": "boolean",
              "options": [
                "Yes",
                "No"
              ]
            },
            {
              "name": "Length of time on Rituxan (rituximab)",
              "type": "string"
            }
          ]
        }
      ]
    }
  ]
}